Cargando…
S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis
SIMPLE SUMMARY: Despite the advance in therapeutic strategy, the prognosis of pancreatic ductal adenocarcinoma (PDAC) is still unsatisfactory, with a 5-year survival rate of less than 9%. As a member of the S100 protein family, S100A10 has been identified as an oncogene in multiple cancers. In PDAC,...
Autores principales: | Lin, Hai, Yang, Pengfei, Li, Bixiang, Chang, Yue, Chen, Yutong, Li, Yaning, Liu, Kecheng, Liang, Xinyue, Chen, Tianliang, Dai, Yalan, Pang, Wenzheng, Zeng, Linjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818352/ https://www.ncbi.nlm.nih.gov/pubmed/36612197 http://dx.doi.org/10.3390/cancers15010202 |
Ejemplares similares
-
Upregulation of Apolipoprotein L6 Improves Tumor Immunotherapy by Inducing Immunogenic Cell Death
por: Liu, Kecheng, et al.
Publicado: (2023) -
ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis
por: Islam, Shajedul, et al.
Publicado: (2021) -
Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer
por: Li, Yaning, et al.
Publicado: (2022) -
Variants in LAMC3 Causes Occipital Cortical Malformation
por: Qian, Xiaohang, et al.
Publicado: (2021) -
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)